Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
127
days
TIM-3 as a therapeutic target in anaplastic thyroid carcinoma: Preclinical and transcriptomic evidence supporting a new immunotherapy avenue
AuthorsMonikongkona Boruah; Riyaz Ahmad Mir; Sameer Rastogi; Kapil Sikka; Shipra Agarwal
AffiliationsDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India
72
days
Plasma anti-ATP7A/ATP7B/COPT1 autoantibodies as potential biomarkers for breast cancer detection
AuthorsPeiqi Yu; Tingzun Nie; Aichen Liu; Lulu Zhang; Wenke Sun; Yihao Liang; Yunhui Qu; Liping Dai; Jingjing Liu
AffiliationsHenan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China; Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou, China; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
46
days
Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis
AuthorsDarin T. Okuda; Benjamin J. Anderson; Sophia M. Taylor; Morgan C. Jones-McCreary; Katy W. Burgess; Crystal M. Wright; Jose R. Santoyo; Peter V. Sguigna; Olaf Stüve; Diem H. Tran; David Y. Light; Tatum M. Moog; Tom G. Punnen
AffiliationsThe University of Texas Southwestern Medical Center, Department of Neurology, Neuroinnovation Program, Multiple Sclerosis & Neuroimmunology Imaging Program, Dallas, TX, USA; The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute, Dallas, TX, USA; College of Arts and Sciences, Department of Biology, Baylor University, Waco, TX, USA; Dallas VA Medical Center, Department of Neurology, Dallas, TX, USA; Valisure, New Haven, CT, USA; Long Island University, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Brooklyn, NY, USA; The University of Texas Southwestern Medical Center School of Medicine, Dallas, TX, USA
83
days
T-cell activation profiles predict outcomes of neoadjuvant therapy in breast cancer
AuthorsChaoni Cai; Jialing Huang; Jinfeng Li; Saixiang Zheng; Dijin Lin; Chaohui Duan; Ying Xu
AffiliationsDepartment of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
39
days
TIGIT-associated immune cell exhaustion in pediatric B-cell acute lymphoblastic leukemia: An integrated clinical and transcriptomic analysis
AuthorsFatemah S. Basingab
AffiliationsDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21585, Saudi Arabia; Immunology Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21859, Saudi Arabia
132
days
Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation
AuthorsShengyu Sun; Bo Zhang; Pengfei Chen; Liang Wu; Zhanfeng Niu
AffiliationsDepartment of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan 750004, China; Ningxia Medical University, Yinchuan 750004, China
201
days
KLF4 modulates macrophage-driven inflammation in diabetic psoriasis-like dermatitis through the TIMP3-ADAM17 axis: A basic research
AuthorsMeichen Jin; Yiyao Li; Yuan Kong; Xiangyi Cheng; Jingbin Zhang
AffiliationsDepartment of Dermatology, General Hospital of Northern Theater Command, No. 83, Wenhua Road, Shenhe District, Shenyang City, Liaoning Province 110000, China; Department of Endocrinology, General Hospital of Northern Theater Command, No. 83, Wenhua, Road, Shenhe District, Shenyang City, Liaoning Province 110000, China
58
days
Clinical and population genetic insights into primary complement component 2 (C2) deficiency: A founder variant in Ashkenazi Jews
AuthorsOded Shamriz; Vered Molho-Pessach; Stephanie Benshushan; Amos J. Simon; Odelia Orbaum-Harel; Enosh Askenasy; Maya Slovik; Avraham Shaag; Oded Volovelsky; Amir Shimonov; Yacov Berkun; Yuval Tal; Sigal Matza-Porges
AffiliationsThe Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada (IMRIC), Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Department of Dermatology, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Department of Pathology, The Faculty of Medicine, Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, Israel; Pediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel; Hemato-Immunology Unit, Hematology Lab and Sheba Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Department of Nephrology, Sheba Medical Center, Ramat Gan, Israel; Department of Genetics, Hadassah Medical Organization, Jerusalem, Israel; Pediatric Nephrology Unit, Hadassah Medical Center and Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel; Wohl Institute for Translational Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Department of Pediatrics, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem, Israel,; Department of Medical Laboratory Sciences, Jerusalem Multidisciplinary College, Jerusalem, Israel.
60
days
Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers
AuthorsMischa H. Koenen; Juana Claus; Myrthe E. Reiche; Geert H. van Weelden; Annemijn Arns; Christa E. van der Gaast-de Jongh; Manon Kolkman; Thijs ten Doesschate; Helen L. Leavis; Janneke H.H.M. van de Wijgert; Marien I. de Jonge; Lilly M. Verhagen
AffiliationsDepartment of Paediatrics, Sophia Children's Hospital, Erasmus Medical Centre, Rotterdam, the Netherlands; Department of Paediatrics, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud Community for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Internal Medicine, Jeroen Bosch Hospital, ’s-Hertogenbosch, the Netherlands; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Paediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands
197
days
Metabolic syndrome and increased inflammatory burden in active rheumatoid arthritis: An exploratory focus on hematologic markers
AuthorsAmina Arroul-Lammali; Dalila Mezioug; Rayene Mammeri; Fadia Rahal; Fella Hanni; Fadila Boudjaafar; Chafika Haouichat; Hafida Rahmouni; Tahar Djamel Touat; Zineb Djeraba; Imene Soufli; Fatmazohra Djaballah-Ider; Sarah Benchabane; Fahima Ameur; Arezki Samer; Rania Sihem Boussa; Houda Belguendouz; Chafia Touil-Boukoffa
AffiliationsLaboratory of Cellular and Molecular Biology (LBCM), Cytokines and NO Synthases Team, Faculty of Biological Sciences, USTHB (University of Sciences and Technology), Algiers, Algeria; Rheumatology Department, Ben Aknoun Hospital EHS, Algiers, Algeria; Rheumatology Department, Douera Hospital EHS, Algiers, Algeria; Member of Algerian Academy of Sciences and Technology (AAST), Algiers, Algeria
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days